Quest Diagnostics Incorporated · NYSE:DGX
Doherty Catherine T. sold 22,105 Quest Diagnostics Incorporated shares (Form 4)
Traded Nov 3, 2026 · Filed Nov 5, 2026
On Nov 3, 2026, Doherty Catherine T. (Executive Vice President) sold 22,105 Quest Diagnostics Incorporated shares at an average US$248.02 for US$5.48M under a trading plan, leaving 71,949 shares. Filed Nov 5, 2026 (Form 4).
- Sold
- 22,105 shares
- Price
- US$248.02 average (US$245.45 to US$251.24)
- Value
- US$5.48M
- Holding after
- 71,949 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Executive Vice President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Common Stock | Award | 4,827 | 71,949 | Direct | |
| Nov 3, 2026 | Common Stock | Option exercise | 22,105 | US$121.81 | 94,054 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 3,818 | US$245.45 | 90,236 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 5,990 | US$246.26 | 84,246 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 1,151 | US$246.98 | 83,095 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 2,358 | US$248.38 | 80,737 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 3,004 | US$249.40 | 77,733 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 2,877 | US$250.49 | 74,856 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 2,907 | US$251.24 | 71,949 | Direct |
Source
Download original · View original at SEC